FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia.

MLA

Pardanani, Animesh, et al. “FIP1L1-PDGFRA Fusion: Prevalence and Clinicopathologic Correlates in 89 Consecutive Patients with Moderate to Severe Eosinophilia.” Blood, vol. 104, no. 10, Nov. 2004, pp. 3038–45. EBSCOhost, https://doi.org/10.1182/blood-2004-03-0787.

APA

Pardanani, A., Brockman, S. R., Paternoster, S. F., Flynn, H. C., Ketterling, R. P., Lasho, T. L., Ho, C.-L., Li, C.-Y., Dewald, G. W., & Tefferi, A. (2004). FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. Blood, 104(10), 3038–3045. https://doi.org/10.1182/blood-2004-03-0787

Chicago

Pardanani, Animesh, Stephanie R Brockman, Sarah F Paternoster, Heather C Flynn, Rhett P Ketterling, Terra L Lasho, Ching-Liang Ho, Chin-Yang Li, Gordon W Dewald, and Ayalew Tefferi. 2004. “FIP1L1-PDGFRA Fusion: Prevalence and Clinicopathologic Correlates in 89 Consecutive Patients with Moderate to Severe Eosinophilia.” Blood 104 (10): 3038–45. doi:10.1182/blood-2004-03-0787.